Hypertension Trial, Recruiting NCT06966713 Sponsor: University of Chicago Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06966713
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are over 18 years old
  • You have a severe traumatic brain injury (TBI), confirmed by a standard brain function scoring test (called the Glasgow Coma Scale) showing a very low score, measured after emergency stabilization and without the effects of sedation or muscle-relaxing medicines
  • Your doctors have determined that you need a device placed to monitor pressure inside your skull and/or oxygen levels in your brain, based on established medical guidelines
  • You are still in the intensive care unit (ICU) at the time of enrollment

Who may not be able to join:

  • Your neurological exam suggests your brain may no longer be functioning (for example, both pupils are fixed and fully enlarged), or the exam results may not be reliable due to a high blood alcohol level or a seizure that happened less than 30 minutes before the exam
  • You are pregnant (confirmed by a urine or blood test)
  • Placing a brain monitoring device is not safe for you — for example, due to uncontrolled bleeding problems or a certain type of skull fracture
  • A legally authorized representative (such as a family member or legal guardian) is not available to give consent on your behalf before the study procedures begin
  • You are already taking part in another clinical trial (though joint enrollment with one specific other trial called BOOST3 may be allowed — confirm with trial site)
  • You are currently a prisoner

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christos Lazaridis, MD, clazaridis@bsd.uchicago.edu

Phone: 7737021220

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 February 2023
Est. completion
13 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Modified Rankin Scale (mRS); Rivermead Post-Concussion Symptoms Questionnaire (RPQ); Glasgow Outcome Scale-Extended (GOSE)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov